These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36928248)

  • 21. Coronavirus-induced autoimmunity.
    Salle V
    Clin Immunol; 2021 May; 226():108694. PubMed ID: 33610741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
    Szekanecz Z; Balog A; Constantin T; Czirják L; Géher P; Kovács L; Kumánovics G; Nagy G; Rákóczi É; Szamosi S; Szűcs G; Vályi-Nagy I
    Expert Rev Mol Med; 2022 Mar; 24():e13. PubMed ID: 35311631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Risk of Autoimmunity Development following mRNA COVID-19 Vaccination.
    Świerkot J; Madej M; Szmyrka M; Korman L; Sokolik R; Andrasiak I; Morgiel E; Sebastian A
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies.
    Ding Z; Wei X; Pan H; Shi H; Shi Y
    Scand J Immunol; 2024 Feb; 99(2):e13344. PubMed ID: 39007954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [SARS-CoV-2 infection and autoimmunity].
    Meyer-Bahlburg A
    Z Rheumatol; 2024 Feb; 83(1):34-40. PubMed ID: 38108865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis.
    Velikova T; Georgiev T
    Rheumatol Int; 2021 Mar; 41(3):509-518. PubMed ID: 33515320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers.
    Borghi MO; Bombaci M; Bodio C; Lonati PA; Gobbini A; Lorenzo M; Torresani E; Dubini A; Bulgarelli I; Solari F; Pregnolato F; Bandera A; Gori A; Parati G; Abrignani S; Grifantini R; Meroni PL
    Front Immunol; 2022; 13():930074. PubMed ID: 35911726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
    Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
    Front Public Health; 2021; 9():778964. PubMed ID: 34888290
    [No Abstract]   [Full Text] [Related]  

  • 30. Autoimmune phenomena following SARS-CoV-2 vaccination.
    Ishay Y; Kenig A; Tsemach-Toren T; Amer R; Rubin L; Hershkovitz Y; Kharouf F
    Int Immunopharmacol; 2021 Oct; 99():107970. PubMed ID: 34280851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.
    Caron P
    Endocrine; 2022 Dec; 78(3):406-417. PubMed ID: 35763241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves' Disease.
    Huang L; Jiang Z; Zhou J; Chen Y; Huang H
    Front Endocrinol (Lausanne); 2022; 13():835880. PubMed ID: 35651979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 infection: a possible induction factor for development of autoimmune diseases?
    Saeedi N; Gohari NSF; Ghalibaf AAM; Dehghan A; Owlia MB
    Immunol Res; 2023 Aug; 71(4):547-553. PubMed ID: 37316687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging Roles of Coronavirus in Autoimmune Diseases.
    Zhou SY; Zhang C; Shu WJ; Chong LY; He J; Xu Z; Pan HF
    Arch Med Res; 2021 Oct; 52(7):665-672. PubMed ID: 33875273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.
    Noor R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.
    Gracia-Ramos AE; Martin-Nares E; Hernández-Molina G
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination.
    Aydoğan Bİ; Ünlütürk U; Cesur M
    Endocrine; 2022 Oct; 78(1):42-46. PubMed ID: 35809159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarcoidal immune reaction following SARS-CoV-2 vaccination.
    Abu Rached N; Mansour R; Susok L; Fried S; Abolmaali N; Lee YP; Gambichler T
    Clin Exp Dermatol; 2022 May; 47(5):970-972. PubMed ID: 34978352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.